Cellular and Molecular Aspects of Blood Cell–Endothelium Interactions in Vascular Disorders

Leukocyte Trafficking in Cardiovascular Disease: Insights from Experimental Models

(2017) Daniel P. Jones et al.   MEDIATORS OF INFLAMMATION

Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis

(2016) Michael A. Gimbrone et al.   CIRCULATION RESEARCH

Combination of Empagliflozin and Linagliptin as Second-Line Therapy in Subjects With Type 2 Diabetes Inadequately Controlled on Metformin

(2015) Ralph A. DeFronzo et al.   DIABETES CARE

Dipeptidyl peptidase-4 deficiency protects against experimental diabetic nephropathy partly by blocking the advanced glycation end products-receptor axis

(2015) Takanori Matsui et al.   LABORATORY INVESTIGATION

The role of platelets in the recruitment of leukocytes during vascular disease

(2015) G. Ed Rainger et al.   PLATELETS

Dual Add-on Therapy in Type 2 Diabetes Poorly Controlled With Metformin Monotherapy: A Randomized Double-Blind Trial of Saxagliptin Plus Dapagliflozin Addition Versus Single Addition of Saxagliptin or Dapagliflozin to Metformin

(2014) Julio Rosenstock et al.   DIABETES CARE

Efficacy and Safety of Canagliflozin, an Inhibitor of Sodium–Glucose Cotransporter 2, When Used in Conjunction With Insulin Therapy in Patients With Type 2 Diabetes

(2014) Bruce Neal et al.   DIABETES CARE

sRAGE and Risk of Diabetes, Cardiovascular Disease, and Death

(2013) E. Selvin et al.   DIABETES

A review of central retinal artery occlusion: clinical presentation and management

(2013) D D Varma et al.   EYE

Mechanisms of Acute Coronary Syndromes and Their Implications for Therapy

(2013) Peter Libby   NEW ENGLAND JOURNAL OF MEDICINE

Glanzmann Thrombasthenia: State of the Art and Future Directions

(2013) Xavier Pillois et al.   SEMINARS IN THROMBOSIS AND HEMOSTASIS

Bernard-Soulier Syndrome: An Update

(2013) Robert Andrews et al.   SEMINARS IN THROMBOSIS AND HEMOSTASIS

Red blood cell phosphatidylserine exposure is responsible for increased erythrocyte adhesion to endothelium in central retinal vein occlusion

(2011) M.-P. WAUTIER et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Differential effect of plasma or erythrocyte AGE-ligands of RAGE on expression of transcripts for receptor isoforms

(2009) N. Grossin et al.   DIABETES & METABOLISM

The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: a report on 241 cases

(2008) J.-J. Kiladjian et al.   BLOOD

Severity of diabetic microvascular complications is associated with a low soluble RAGE level

(2008) N. Grossin et al.   DIABETES & METABOLISM

Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE–/– mice

(2008) Evis Harja et al.   JOURNAL OF CLINICAL INVESTIGATION

Identification, classification, and expression of RAGE gene splice variants

(2007) Barry I. Hudson et al.   FASEB JOURNAL